Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Sampo Q4’24: Recommendation turned positive

Sampo

Sampo’s Q4’24 report was strong and contained no negatives as such. Analyst Sauli Vilén discusses the factors behind the strong report. We also take a look at the outlook for 2025 and hear the motivation for giving the stock a positive recommendation.  

00:06 Q4 tops & flops
01:43 Topdanmark merger & synergies
04:53 Change in guidance practice
06:20 Share split
07:06 Outlook for 2025
11:53 Valuation & recommendation

Read the Q4'24 research: Payout outlook more generous than before

Stay up to date
Analyst Interviews

Recent videos

HCA Morgenbørs 06/03 - Investorerne finder lidt ro efter en uge præget af usikkerhed
06.03.2026, 09.25 Zealand Pharma
Aiforia, Webcast, H2, 2025
06.03.2026, 09.00 Aiforia Technologies
Nightingale, Webcast, Half-year financial report 1 July–31 December 2025
05.03.2026, 13.00 Nightingale Health
Solwers, Webcast, Q4'25
05.03.2026, 11.00 Solwers
Orthex, Webcast, Q4'25
05.03.2026, 10.00 Orthex
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.